ログイン

MUST KNOW 2

MUST KNOW 2
100問 • 1年前
  • Yves Laure Pimentel
  • 通報

    問題一覧

  • 1

    CD4+: CD8+ ratio NV =

    2:1

  • 2

    CD4+: CD8+ ratio Abn =

    0.5:1 or 1:2 (HIV)

  • 3

    Abn = 0.5:1 or 1:2

    (HIV)

  • 4

    CD4+ cells: <200/μL

    AIDS

  • 5

    AIDS CD4+ cells:

    <200/μL

  • 6

    AIDS (NV = ?)

    500-1300/µL

  • 7

    Immature T cell

    Double (-) thymocytes

  • 8

    Double (-) thymocytes (+) CD?

    CD2, CD5, CD7

  • 9

    Double (-) thymocytes (-) CD?

    CD4, CD8

  • 10

    Double (+) thymocytes (+)

    (+) CD4, CD8

  • 11

    Mature T cell

    CD4+/CD8+

  • 12

    2’ lymphoid organ CD25+ = receptor for IL 2 ? lymphocyte proliferation

    Activated T cell

  • 13

    2’ lymphoid organ ? = receptor for IL 2 -> lymphocyte proliferation

    CD25+

  • 14

    Secretes lymphokines

    Sensitized T cell

  • 15

    Secrete IFN-Y and IL2

    Th1 cells

  • 16

    Th1 cells Secrete

    IFN-γ and IL2

  • 17

    Secrete IL4 and IL5

    Th2 cells

  • 18

    Th2 cells Secrete

    IL4 and IL5

  • 19

    Activation of Tc, DH

    Th1 cells

  • 20

    Activate B cells

    Th2 cells

  • 21

    FOUND IN BM

    Pro-B cells

  • 22

    Pro-B cells HC =

    chromosome 14

  • 23

    μ chains on cytoplasm

    Pre-B cells

  • 24

    Pre-B cells κ =

    chromosome 2

  • 25

    Pre-B cells = chromosome 2

    κ

  • 26

    Pre-B cells = chromosome 22

    λ

  • 27

    Pre-B cells λ =

    chromosome 22

  • 28

    IgM on surface (monomer)

    Immature B cells

  • 29

    = receptor for EBV

    CD 21

  • 30

    CD 21 = receptor for

    EBV

  • 31

    Immature B cells (+)

    CD21, CD35

  • 32

    IgD on surface

    Mature B cells

  • 33

    ^^ IgM density

    Mature B cells

  • 34

    CD25+

    Activated B cells

  • 35

    Activated B cells

    CD25+

  • 36

    (-) surface Ig (-) surface markers ^ cytoplasmic Ig’s -> Ab’s

    Plasma cells

  • 37

    CALLA- common acute lymphoblastic leukemia antigen

    CD10

  • 38

    CD10

    CALLA- common acute lymphoblastic leukemia antigen

  • 39

    Light scatter Forward LS = cell size Side/90O LS = cell granularity/complexity

    Cell flow cytometry

  • 40

    Cell flow cytometry Light scatter = cell size

    Forward LS

  • 41

    Cell flow cytometry Light scatter Forward LS =

    cell size

  • 42

    Cell flow cytometry Light scatter Side/90O LS =

    cell granularity/complexity

  • 43

    Cell flow cytometry Light scatter = cell granularity/complexity

    Side/90O LS

  • 44

    FOR Labeled monoclonal antibodies

    Fluorescence microscopy

  • 45

    Rosette test = T cells (CD2)

    E-rosette assay

  • 46

    occurs when antibody in the presence of complement is bound to the surface of a red blood cell.

    Erythrocyte antibody complement rosettE (EAC)

  • 47

    EAC (Erythrocyte Ab Complement rosette) =system for recognition of ?

    B-cells

  • 48

    T cell Function

    CMI- CELL MEDIATED IMMUNITY

  • 49

    B cell Function

    HI- HUMORAL IMMUNITY

  • 50

    T cell Lifespan

    Longer

  • 51

    B cell Lifespan

    Shorter

  • 52

    T cell Soluble substances

    Lymphokines

  • 53

    B cell Soluble substances

    Antibodies

  • 54

    T cell ID

    E-rosette

  • 55

    Rosette test = B cells

    EAC (Erythrocyte Ab Complement rosette)

  • 56

    B cell ID

    Surface immunoglobulins

  • 57

    which stimulate cell division, primarily by relieving intracellular negative controls that otherwise block progress through the cell cycle.

    Mitogens

  • 58

    activates T cells and natural killer cells and triggers anticancer immune responses.

    Concanavalin A

  • 59

    STIMULATOR: Mitogen T cell

    Concanavalin A Phytohemagglutinin Pokeweed mitogen

  • 60

    STIMULATOR: Mitogen B cell

    Lipopolysaccharide Pokeweed mitogen

  • 61

    Substances that cause cells to divide

    Mitogen

  • 62

    Lymphocyte capping consist of

    B cells

  • 63

    The HLA system is located on the short arm of

    chromosome 6

  • 64

    The HLA system is located on the ? of chromosome 6

    short arm

  • 65

    is located on the short arm of chromosome 6

    HLA system

  • 66

    Class I MHC Locus/Ag =

    HLA - A, B, C

  • 67

    Class I MHC Chain structure =

    α-chain + β2 microglobulin

  • 68

    molecules present primarily endogenous antigens Endogenous antigen

    Class I MHC

  • 69

    Presents antigen to CD8+ cells

    Class I MHC

  • 70

    Class I MHC Cell distribution =

    all nucleated cells

  • 71

    For antigen found on surface of the cell

    Class II MHC

  • 72

    Class II MHC Locus/Ag =

    HLA - DP, DQ, DR

  • 73

    Class II MHC Chain structure =

    α-chain + β-chain

  • 74

    Class II MHC Cell distribution =

    B cells and macrophages

  • 75

    Presents antigen to CD4+ cells

    Class II MHC

  • 76

    Class III MHC Locus/Ag =

    “CCTB” C2, C4, TNF, Factor B

  • 77

    Most efficient APC

    Dendritic cells

  • 78

    DC/Dendritic cells in skin

    Langerhans cells

  • 79

    T cell growth factor

    IL-2

  • 80

    Stimulates lymphocyte proliferation

    IL-2

  • 81

    Growth of stem cells and differentiation of blood cells

    IL-3

  • 82

    B cell growth factor 1

    IL-4

  • 83

    B cell growth factor 2

    IL-5

  • 84

    : eosinophil differentiation

    IL-5

  • 85

    Differentiates B cell ?

    plasma cell

  • 86

    re essential for IgE production and eosinophilia, respectively, and are produced by mast cells in allergic conditions, for which glucocorticoids are widely used therapeutically.

    Interleukin 4 (IL-4) and IL-5

  • 87

    Enhance antibody production of plasma cell

    IL-6

  • 88

    NK stimulating factor

    IL-12

  • 89

    Activates NK cells and cytotoxic T lymphocytes

    IL-12

  • 90

    ^^^ Antigenic

    Heteroantigen

  • 91

    1. Hyperacute = w/in mins 2. Accelerated = 2-5 days 3. Acute = 7-21 days 4. Chronic = >3 months

    Graft rejection

  • 92

    Graft rejection = w/in mins

    Hyperacute

  • 93

    Graft rejection Hyperacute =

    w/in mins

  • 94

    Graft rejection = 2-5 days

    Accelerated

  • 95

    Graft rejection Accelerated =

    2-5 days

  • 96

    Graft rejection = 7-21 days

    Acute

  • 97

    Graft rejection Acute =

    7-21 days

  • 98

    Graft rejection Chronic =

    >3 months

  • 99

    Graft rejection = >3 months

    Chronic

  • 100

    Potent antigen kda

    >10 kDa

  • other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    Yves Laure Pimentel · 89問 · 2年前

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    89問 • 2年前
    Yves Laure Pimentel

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    Yves Laure Pimentel · 86問 · 2年前

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    86問 • 2年前
    Yves Laure Pimentel

    MTLBE..

    MTLBE..

    Yves Laure Pimentel · 35問 · 2年前

    MTLBE..

    MTLBE..

    35問 • 2年前
    Yves Laure Pimentel

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    Yves Laure Pimentel · 19問 · 1年前

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    19問 • 1年前
    Yves Laure Pimentel

    CC-OSMOMETRY

    CC-OSMOMETRY

    Yves Laure Pimentel · 14問 · 1年前

    CC-OSMOMETRY

    CC-OSMOMETRY

    14問 • 1年前
    Yves Laure Pimentel

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    Yves Laure Pimentel · 43問 · 1年前

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    43問 • 1年前
    Yves Laure Pimentel

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    Yves Laure Pimentel · 49問 · 2年前

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    49問 • 2年前
    Yves Laure Pimentel

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    Yves Laure Pimentel · 97問 · 2年前

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    97問 • 2年前
    Yves Laure Pimentel

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    Yves Laure Pimentel · 57問 · 2年前

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    57問 • 2年前
    Yves Laure Pimentel

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    Yves Laure Pimentel · 63問 · 2年前

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    63問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 37問 · 2年前

    PROTEINS

    PROTEINS

    37問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    Yves Laure Pimentel · 91問 · 2年前

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    91問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    Yves Laure Pimentel · 98問 · 2年前

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    98問 • 2年前
    Yves Laure Pimentel

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    Yves Laure Pimentel · 61問 · 2年前

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    61問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 1

    Liver Function Test 1

    Yves Laure Pimentel · 100問 · 2年前

    Liver Function Test 1

    Liver Function Test 1

    100問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 2

    Liver Function Test 2

    Yves Laure Pimentel · 96問 · 2年前

    Liver Function Test 2

    Liver Function Test 2

    96問 • 2年前
    Yves Laure Pimentel

    TUMOR MARKERS

    TUMOR MARKERS

    Yves Laure Pimentel · 33問 · 2年前

    TUMOR MARKERS

    TUMOR MARKERS

    33問 • 2年前
    Yves Laure Pimentel

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    Yves Laure Pimentel · 41問 · 2年前

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    41問 • 2年前
    Yves Laure Pimentel

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    Yves Laure Pimentel · 17問 · 2年前

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    17問 • 2年前
    Yves Laure Pimentel

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    Yves Laure Pimentel · 14問 · 2年前

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    14問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 71問 · 2年前

    PROTEINS

    PROTEINS

    71問 • 2年前
    Yves Laure Pimentel

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    Yves Laure Pimentel · 7問 · 2年前

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    7問 • 2年前
    Yves Laure Pimentel

    ELECTROLYTES

    ELECTROLYTES

    Yves Laure Pimentel · 10問 · 2年前

    ELECTROLYTES

    ELECTROLYTES

    10問 • 2年前
    Yves Laure Pimentel

    DRUGS

    DRUGS

    Yves Laure Pimentel · 27問 · 2年前

    DRUGS

    DRUGS

    27問 • 2年前
    Yves Laure Pimentel

    TOXIC AGENTS:

    TOXIC AGENTS:

    Yves Laure Pimentel · 12問 · 2年前

    TOXIC AGENTS:

    TOXIC AGENTS:

    12問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    Yves Laure Pimentel · 100問 · 2年前

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    100問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    Yves Laure Pimentel · 29問 · 2年前

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    29問 • 2年前
    Yves Laure Pimentel

    hema diseases

    hema diseases

    Yves Laure Pimentel · 25問 · 2年前

    hema diseases

    hema diseases

    25問 • 2年前
    Yves Laure Pimentel

    AML

    AML

    Yves Laure Pimentel · 43問 · 2年前

    AML

    AML

    43問 • 2年前
    Yves Laure Pimentel

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    Yves Laure Pimentel · 71問 · 2年前

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    71問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    Yves Laure Pimentel · 31問 · 2年前

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    31問 • 2年前
    Yves Laure Pimentel

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    Yves Laure Pimentel · 34問 · 2年前

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    34問 • 2年前
    Yves Laure Pimentel

    PLATELET DISORDERS

    PLATELET DISORDERS

    Yves Laure Pimentel · 37問 · 2年前

    PLATELET DISORDERS

    PLATELET DISORDERS

    37問 • 2年前
    Yves Laure Pimentel

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    Yves Laure Pimentel · 100問 · 2年前

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    100問 • 2年前
    Yves Laure Pimentel

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    Yves Laure Pimentel · 12問 · 2年前

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    12問 • 2年前
    Yves Laure Pimentel

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    Yves Laure Pimentel · 39問 · 2年前

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    39問 • 2年前
    Yves Laure Pimentel

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    Yves Laure Pimentel · 55問 · 2年前

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    55問 • 2年前
    Yves Laure Pimentel

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    Yves Laure Pimentel · 37問 · 2年前

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    37問 • 2年前
    Yves Laure Pimentel

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    Yves Laure Pimentel · 44問 · 2年前

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    44問 • 2年前
    Yves Laure Pimentel

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    Yves Laure Pimentel · 50問 · 2年前

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    50問 • 2年前
    Yves Laure Pimentel

    1. HISTORY

    1. HISTORY

    Yves Laure Pimentel · 69問 · 2年前

    1. HISTORY

    1. HISTORY

    69問 • 2年前
    Yves Laure Pimentel

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    Yves Laure Pimentel · 38問 · 2年前

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    38問 • 2年前
    Yves Laure Pimentel

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    Yves Laure Pimentel · 21問 · 2年前

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    21問 • 2年前
    Yves Laure Pimentel

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    Yves Laure Pimentel · 15問 · 2年前

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    15問 • 2年前
    Yves Laure Pimentel

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    Yves Laure Pimentel · 32問 · 2年前

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    32問 • 2年前
    Yves Laure Pimentel

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    Yves Laure Pimentel · 30問 · 2年前

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    30問 • 2年前
    Yves Laure Pimentel

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    Yves Laure Pimentel · 38問 · 2年前

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    38問 • 2年前
    Yves Laure Pimentel

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    Yves Laure Pimentel · 48問 · 2年前

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    48問 • 2年前
    Yves Laure Pimentel

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    Yves Laure Pimentel · 35問 · 2年前

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    35問 • 2年前
    Yves Laure Pimentel

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 18問 · 2年前

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    18問 • 2年前
    Yves Laure Pimentel

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    Yves Laure Pimentel · 44問 · 2年前

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    44問 • 2年前
    Yves Laure Pimentel

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 23問 · 2年前

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    23問 • 2年前
    Yves Laure Pimentel

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    Yves Laure Pimentel · 34問 · 2年前

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    34問 • 2年前
    Yves Laure Pimentel

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    Yves Laure Pimentel · 12問 · 2年前

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    12問 • 2年前
    Yves Laure Pimentel

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    Yves Laure Pimentel · 16問 · 2年前

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    16問 • 2年前
    Yves Laure Pimentel

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    Yves Laure Pimentel · 15問 · 2年前

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    15問 • 2年前
    Yves Laure Pimentel

    12. ANTIBODY

    12. ANTIBODY

    Yves Laure Pimentel · 79問 · 2年前

    12. ANTIBODY

    12. ANTIBODY

    79問 • 2年前
    Yves Laure Pimentel

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    Yves Laure Pimentel · 97問 · 2年前

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    97問 • 2年前
    Yves Laure Pimentel

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    Yves Laure Pimentel · 11問 · 2年前

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    11問 • 2年前
    Yves Laure Pimentel

    1. INTERLEUKINS

    1. INTERLEUKINS

    Yves Laure Pimentel · 23問 · 2年前

    1. INTERLEUKINS

    1. INTERLEUKINS

    23問 • 2年前
    Yves Laure Pimentel

    2. INTERFERONS

    2. INTERFERONS

    Yves Laure Pimentel · 28問 · 2年前

    2. INTERFERONS

    2. INTERFERONS

    28問 • 2年前
    Yves Laure Pimentel

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    Yves Laure Pimentel · 8問 · 2年前

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    8問 • 2年前
    Yves Laure Pimentel

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 19問 · 2年前

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    19問 • 2年前
    Yves Laure Pimentel

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 76問 · 2年前

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    76問 • 2年前
    Yves Laure Pimentel

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    Yves Laure Pimentel · 21問 · 2年前

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    21問 • 2年前
    Yves Laure Pimentel

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    Yves Laure Pimentel · 29問 · 2年前

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    29問 • 2年前
    Yves Laure Pimentel

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    Yves Laure Pimentel · 19問 · 2年前

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    19問 • 2年前
    Yves Laure Pimentel

    19. CYTOKINES

    19. CYTOKINES

    Yves Laure Pimentel · 22問 · 2年前

    19. CYTOKINES

    19. CYTOKINES

    22問 • 2年前
    Yves Laure Pimentel

    20. INTERLEUKINS

    20. INTERLEUKINS

    Yves Laure Pimentel · 24問 · 2年前

    20. INTERLEUKINS

    20. INTERLEUKINS

    24問 • 2年前
    Yves Laure Pimentel

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    Yves Laure Pimentel · 21問 · 2年前

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21問 • 2年前
    Yves Laure Pimentel

    1. SERO

    1. SERO

    Yves Laure Pimentel · 54問 · 2年前

    1. SERO

    1. SERO

    54問 • 2年前
    Yves Laure Pimentel

    2. PRECIPITATION

    2. PRECIPITATION

    Yves Laure Pimentel · 38問 · 2年前

    2. PRECIPITATION

    2. PRECIPITATION

    38問 • 2年前
    Yves Laure Pimentel

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    Yves Laure Pimentel · 17問 · 2年前

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    17問 • 2年前
    Yves Laure Pimentel

    4. OUCHTERLONY

    4. OUCHTERLONY

    Yves Laure Pimentel · 15問 · 2年前

    4. OUCHTERLONY

    4. OUCHTERLONY

    15問 • 2年前
    Yves Laure Pimentel

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    Yves Laure Pimentel · 9問 · 2年前

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    9問 • 2年前
    Yves Laure Pimentel

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    Yves Laure Pimentel · 11問 · 2年前

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    11問 • 2年前
    Yves Laure Pimentel

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    Yves Laure Pimentel · 29問 · 2年前

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    29問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    CD4+: CD8+ ratio NV =

    2:1

  • 2

    CD4+: CD8+ ratio Abn =

    0.5:1 or 1:2 (HIV)

  • 3

    Abn = 0.5:1 or 1:2

    (HIV)

  • 4

    CD4+ cells: <200/μL

    AIDS

  • 5

    AIDS CD4+ cells:

    <200/μL

  • 6

    AIDS (NV = ?)

    500-1300/µL

  • 7

    Immature T cell

    Double (-) thymocytes

  • 8

    Double (-) thymocytes (+) CD?

    CD2, CD5, CD7

  • 9

    Double (-) thymocytes (-) CD?

    CD4, CD8

  • 10

    Double (+) thymocytes (+)

    (+) CD4, CD8

  • 11

    Mature T cell

    CD4+/CD8+

  • 12

    2’ lymphoid organ CD25+ = receptor for IL 2 ? lymphocyte proliferation

    Activated T cell

  • 13

    2’ lymphoid organ ? = receptor for IL 2 -> lymphocyte proliferation

    CD25+

  • 14

    Secretes lymphokines

    Sensitized T cell

  • 15

    Secrete IFN-Y and IL2

    Th1 cells

  • 16

    Th1 cells Secrete

    IFN-γ and IL2

  • 17

    Secrete IL4 and IL5

    Th2 cells

  • 18

    Th2 cells Secrete

    IL4 and IL5

  • 19

    Activation of Tc, DH

    Th1 cells

  • 20

    Activate B cells

    Th2 cells

  • 21

    FOUND IN BM

    Pro-B cells

  • 22

    Pro-B cells HC =

    chromosome 14

  • 23

    μ chains on cytoplasm

    Pre-B cells

  • 24

    Pre-B cells κ =

    chromosome 2

  • 25

    Pre-B cells = chromosome 2

    κ

  • 26

    Pre-B cells = chromosome 22

    λ

  • 27

    Pre-B cells λ =

    chromosome 22

  • 28

    IgM on surface (monomer)

    Immature B cells

  • 29

    = receptor for EBV

    CD 21

  • 30

    CD 21 = receptor for

    EBV

  • 31

    Immature B cells (+)

    CD21, CD35

  • 32

    IgD on surface

    Mature B cells

  • 33

    ^^ IgM density

    Mature B cells

  • 34

    CD25+

    Activated B cells

  • 35

    Activated B cells

    CD25+

  • 36

    (-) surface Ig (-) surface markers ^ cytoplasmic Ig’s -> Ab’s

    Plasma cells

  • 37

    CALLA- common acute lymphoblastic leukemia antigen

    CD10

  • 38

    CD10

    CALLA- common acute lymphoblastic leukemia antigen

  • 39

    Light scatter Forward LS = cell size Side/90O LS = cell granularity/complexity

    Cell flow cytometry

  • 40

    Cell flow cytometry Light scatter = cell size

    Forward LS

  • 41

    Cell flow cytometry Light scatter Forward LS =

    cell size

  • 42

    Cell flow cytometry Light scatter Side/90O LS =

    cell granularity/complexity

  • 43

    Cell flow cytometry Light scatter = cell granularity/complexity

    Side/90O LS

  • 44

    FOR Labeled monoclonal antibodies

    Fluorescence microscopy

  • 45

    Rosette test = T cells (CD2)

    E-rosette assay

  • 46

    occurs when antibody in the presence of complement is bound to the surface of a red blood cell.

    Erythrocyte antibody complement rosettE (EAC)

  • 47

    EAC (Erythrocyte Ab Complement rosette) =system for recognition of ?

    B-cells

  • 48

    T cell Function

    CMI- CELL MEDIATED IMMUNITY

  • 49

    B cell Function

    HI- HUMORAL IMMUNITY

  • 50

    T cell Lifespan

    Longer

  • 51

    B cell Lifespan

    Shorter

  • 52

    T cell Soluble substances

    Lymphokines

  • 53

    B cell Soluble substances

    Antibodies

  • 54

    T cell ID

    E-rosette

  • 55

    Rosette test = B cells

    EAC (Erythrocyte Ab Complement rosette)

  • 56

    B cell ID

    Surface immunoglobulins

  • 57

    which stimulate cell division, primarily by relieving intracellular negative controls that otherwise block progress through the cell cycle.

    Mitogens

  • 58

    activates T cells and natural killer cells and triggers anticancer immune responses.

    Concanavalin A

  • 59

    STIMULATOR: Mitogen T cell

    Concanavalin A Phytohemagglutinin Pokeweed mitogen

  • 60

    STIMULATOR: Mitogen B cell

    Lipopolysaccharide Pokeweed mitogen

  • 61

    Substances that cause cells to divide

    Mitogen

  • 62

    Lymphocyte capping consist of

    B cells

  • 63

    The HLA system is located on the short arm of

    chromosome 6

  • 64

    The HLA system is located on the ? of chromosome 6

    short arm

  • 65

    is located on the short arm of chromosome 6

    HLA system

  • 66

    Class I MHC Locus/Ag =

    HLA - A, B, C

  • 67

    Class I MHC Chain structure =

    α-chain + β2 microglobulin

  • 68

    molecules present primarily endogenous antigens Endogenous antigen

    Class I MHC

  • 69

    Presents antigen to CD8+ cells

    Class I MHC

  • 70

    Class I MHC Cell distribution =

    all nucleated cells

  • 71

    For antigen found on surface of the cell

    Class II MHC

  • 72

    Class II MHC Locus/Ag =

    HLA - DP, DQ, DR

  • 73

    Class II MHC Chain structure =

    α-chain + β-chain

  • 74

    Class II MHC Cell distribution =

    B cells and macrophages

  • 75

    Presents antigen to CD4+ cells

    Class II MHC

  • 76

    Class III MHC Locus/Ag =

    “CCTB” C2, C4, TNF, Factor B

  • 77

    Most efficient APC

    Dendritic cells

  • 78

    DC/Dendritic cells in skin

    Langerhans cells

  • 79

    T cell growth factor

    IL-2

  • 80

    Stimulates lymphocyte proliferation

    IL-2

  • 81

    Growth of stem cells and differentiation of blood cells

    IL-3

  • 82

    B cell growth factor 1

    IL-4

  • 83

    B cell growth factor 2

    IL-5

  • 84

    : eosinophil differentiation

    IL-5

  • 85

    Differentiates B cell ?

    plasma cell

  • 86

    re essential for IgE production and eosinophilia, respectively, and are produced by mast cells in allergic conditions, for which glucocorticoids are widely used therapeutically.

    Interleukin 4 (IL-4) and IL-5

  • 87

    Enhance antibody production of plasma cell

    IL-6

  • 88

    NK stimulating factor

    IL-12

  • 89

    Activates NK cells and cytotoxic T lymphocytes

    IL-12

  • 90

    ^^^ Antigenic

    Heteroantigen

  • 91

    1. Hyperacute = w/in mins 2. Accelerated = 2-5 days 3. Acute = 7-21 days 4. Chronic = >3 months

    Graft rejection

  • 92

    Graft rejection = w/in mins

    Hyperacute

  • 93

    Graft rejection Hyperacute =

    w/in mins

  • 94

    Graft rejection = 2-5 days

    Accelerated

  • 95

    Graft rejection Accelerated =

    2-5 days

  • 96

    Graft rejection = 7-21 days

    Acute

  • 97

    Graft rejection Acute =

    7-21 days

  • 98

    Graft rejection Chronic =

    >3 months

  • 99

    Graft rejection = >3 months

    Chronic

  • 100

    Potent antigen kda

    >10 kDa